{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Bavarian Nordic Immunotherapeutics (\"BNIT\") located in Mountain View, CA, USA.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2012/05/30/2012-13006.html","cfr_references":[],"citation":"77 FR 31864","comment_url":null,"comments_close_on":"2012-06-29","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before June 29, 2012 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2012-13006","effective_on":null,"end_page":31866,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2012/05/30/2012-13006.xml","html_url":"https://www.federalregister.gov/documents/2012/05/30/2012-13006/prospective-grant-of-exclusive-license-development-of-panvactm-and-tumor-associated-antigens-as","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2012-13006?publication_date=2012-05-30","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2012-05-30/2012-13006/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":69,"last_updated":"2026-09-22 06:15:08 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2012-05-30/pdf/2012-13006.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2012-13006.pdf?1338296003","publication_date":"2012-05-30","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2012/05/30/2012-13006.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2012-06-19T08:14:26Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":31864,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of PANVACTM and Tumor Associated Antigens as Colorectal Cancer Vaccine","toc_doc":"Development of PANVAC and Tumor Associated Antigens as Colorectal Cancer Vaccine","toc_subject":"Prospective Grants of Exclusive Licenses:","topics":[],"type":"Notice","volume":77}